Clinical Trials Directory

Trials / Unknown

UnknownNCT05266651

Efficiency of Tadalafil for Management of Female Sexual Dysfunction

Efficiency of Tadalafil for Management of Female Sexual Dysfunction in Females With Genital Mutilation

Status
Unknown
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
24 (estimated)
Sponsor
Kasr El Aini Hospital · Academic / Other
Sex
Female
Age
25 Years – 35 Years
Healthy volunteers
Not accepted

Summary

comparative study between tadalafil versus placebo effect for the management of circumsized female

Detailed description

the group of patient will be randomly divided into 2 groups, half of the patients will receive tadalafil and the other half will receive placebo

Conditions

Interventions

TypeNameDescription
DRUGTadalafil 5mgoral tablets for one month duration
DRUGPlacebooral tablets for one month duration

Timeline

Start date
2022-03-10
Primary completion
2022-05-01
Completion
2022-05-01
First posted
2022-03-04
Last updated
2022-03-04

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05266651. Inclusion in this directory is not an endorsement.

Efficiency of Tadalafil for Management of Female Sexual Dysfunction (NCT05266651) · Clinical Trials Directory